欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体
Anti-CD19 mAbs [Nb1](MABL-3642)
  • Anti-CD19 mAbs [Nb1](MABL-3642)

Anti-CD19 mAbs [Nb1](MABL-3642)

简要描述:

For Research Use Only. Not for diagnostic or therapeutic use.

产品参数:

Cat. No.:MABL-3642

Application:in vitro, SPR

Isotype:Engineer antibody

Species Reactivity:Human

Clone No.:Nb1

产品价格:¥0

详细介绍
Cat. No.
MABL-3642
Application
in vitro, SPR
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
Nb1
From
Recombinant Antibody
Specificity
This antibody is specific for human CD19.
Alternative Names
B‑lymphocyte antigen CD19; B‑lymphocyte surface antigen B4; Differentiation antigen CD19; T‑cell surface antigen Leu‑12
UniProt
P15391
Immunogen
The original antibody was isolated from a Bactrian camel naïve phage display library. Isolation was accomplished through four rounds of phage panning against biotinylated human CD19 immobilized on streptavidin magnetic beads.
Application Notes
The original antibody (camelid VHH) was generated and characterized. The nanobody's sequence was cloned into an expression vector with Fc and His‑tags, yielding a ~50 kDa Nb‑Fc fusion protein that retained the compact VHH structure and exhibited strong binding specificity for CD19, with a dissociation constant of 0.29 µM as determined by surface plasmon resonance. The nanobody was subsequently incorporated as the antigen‑recognition domain in a second‑generation chimeric antigen receptor (CAR) containing CD8, 4‑1BB, and CD3ζ signaling motifs. When transduced into human T cells in vitro, the resulting Nb1‑CAR‑T cells showed efficient activation, proliferation, IL‑2 release, and antigen‑dependent cytotoxicity against CD19‑positive lymphoma and leukemia cells (Daudi, Raji), demonstrating that the nanobody enables potent and specific CAR‑T‑mediated killing of B‑cell malignancies (Wang et al., 2021; PMID: 34429118).
Antibody First Published
Wang et al. Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells Cancer Cell Int. 2021 Aug 24;21(1):450. doi: 10.1186/s12935-021-02151-z. PMID:34429118
Note on publication
The original publication describes the development of nanobody-based CAR-T cells targeting CD19 and CD20, demonstrating their strong and specific cytotoxic activity against lymphoma cell lines and patient-derived tumor cells in vitro.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号